$0.64 Earnings Per Share Expected for Prestige Consumer Healthcare Inc (NYSE:PBH) This Quarter
Analysts forecast that Prestige Consumer Healthcare Inc (NYSE:PBH) will post earnings per share (EPS) of $0.64 for the current quarter, Zacks reports. Four analysts have made estimates for Prestige Consumer Healthcare’s earnings. The lowest EPS estimate is $0.62 and the highest is $0.65. Prestige Consumer Healthcare posted earnings per share of $0.68 during the same quarter last year, which would indicate a negative year over year growth rate of 5.9%. The company is scheduled to announce its next quarterly earnings report before the market opens on Thursday, August 1st.
On average, analysts expect that Prestige Consumer Healthcare will report full-year earnings of $2.81 per share for the current financial year, with EPS estimates ranging from $2.80 to $2.82. For the next financial year, analysts forecast that the business will report earnings of $2.95 per share, with EPS estimates ranging from $2.89 to $2.99. Zacks Investment Research’s earnings per share calculations are an average based on a survey of research firms that follow Prestige Consumer Healthcare.
Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings data on Thursday, May 9th. The company reported $0.72 earnings per share for the quarter, topping analysts’ consensus estimates of $0.70 by $0.02. The business had revenue of $241.03 million for the quarter, compared to analyst estimates of $237.22 million. Prestige Consumer Healthcare had a positive return on equity of 12.45% and a negative net margin of 3.67%. Prestige Consumer Healthcare’s quarterly revenue was down 5.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.62 EPS.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in PBH. Diversified Trust Co grew its holdings in Prestige Consumer Healthcare by 8.2% during the second quarter. Diversified Trust Co now owns 8,575 shares of the company’s stock valued at $272,000 after purchasing an additional 650 shares during the period. Primecap Management Co. CA raised its position in Prestige Consumer Healthcare by 51.6% during the first quarter. Primecap Management Co. CA now owns 42,600 shares of the company’s stock valued at $1,274,000 after purchasing an additional 14,500 shares in the last quarter. Champlain Investment Partners LLC raised its position in Prestige Consumer Healthcare by 2.2% during the first quarter. Champlain Investment Partners LLC now owns 2,088,940 shares of the company’s stock valued at $62,480,000 after purchasing an additional 44,975 shares in the last quarter. The Manufacturers Life Insurance Company raised its position in Prestige Consumer Healthcare by 10.3% during the first quarter. The Manufacturers Life Insurance Company now owns 874,566 shares of the company’s stock valued at $26,158,000 after purchasing an additional 81,568 shares in the last quarter. Finally, AJO LP raised its position in Prestige Consumer Healthcare by 22.6% during the first quarter. AJO LP now owns 144,056 shares of the company’s stock valued at $4,309,000 after purchasing an additional 26,560 shares in the last quarter.
PBH stock traded down $0.01 during midday trading on Friday, reaching $30.96. 420,100 shares of the stock were exchanged, compared to its average volume of 502,133. The company has a market cap of $1.59 billion, a PE ratio of 11.15, a PEG ratio of 1.76 and a beta of 0.93. Prestige Consumer Healthcare has a 52 week low of $26.25 and a 52 week high of $41.76. The company has a quick ratio of 1.43, a current ratio of 2.37 and a debt-to-equity ratio of 1.64. The firm has a fifty day moving average of $30.65.
Prestige Consumer Healthcare Company Profile
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.
Recommended Story: The benefits and drawbacks of dollar cost averaging
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.